Allergy Therapeutics financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2004 2023 2024
Rev. Revenue
£20.61M £23.56M £25.74M £31.02M £37.76M £40.75M £41.55M £41.28M £39.28M £41.96M £43.23M £48.51M £64.14M £68.35M £73.72M £78.20M £84.33M £72.77M £18.00M £59.59M £0.00M
GM % Gross Margin %
76.45% 72.35% 60.89% 64.98% 64.08% 72.60% 68.18% 66.88% 69.57% 71.51% 71.83% 71.00% 73.85% 75.11% 75.07% 74.17% 73.79% 68.03% 69.37% 55.79% 0.00%
OM Operating Margin
-8.75% -28.50% -102.47% -50.68% -13.96% 3.39% -0.64% 2.13% 1.22% 2.39% 1.71% -24.99% -3.09% -9.81% -2.49% 6.38% 4.66% -17.00% 8.64% -59.05% 0.00%
EPS Earnings Per Share
£-0.08 £0.00
Div. Dividends
£0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
41.03m 62.95m 81.95m 81.95m 81.95m 292.95m 310.76m 310.77m 409.84m 409.87m 410.06m 586.85m 593.44m 594.12m 636.17m 636.17m 639.86m 641.8m 0m 679.1m 4766.44m
OCF Operating Cash Flow
£-0.02M £-8.10M £-18.20M £-19.32M £-0.44M £1.70M £-2.03M £2.88M £2.43M £2.17M £3.12M £-11.84M £0.18M £-3.80M £5.60M £12.01M £8.40M £-13.82M £1.87M £-28.88M £0.00M
FCF Free Cash Flow
£-0.92M £-10.29M £-21.02M £-21.79M £-1.87M £0.06M £-3.18M £2.45M £1.77M £1.28M £2.03M £-13.07M £-1.32M £-5.81M £2.79M £9.75M £5.64M £-17.65M £1.11M £-34.46M £0.00M
FCFS Free Cash Flow Per Share
£-0.02 £-0.16 £-0.26 £-0.27 £-0.03 £0.00 £-0.01 £0.00 £0.00 £0.00 £0.00 £-0.02 £-0.00 £-0.01 £0.00 £0.01 £0.01 £-0.03 £0.03 £-0.05 £0.00